• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群可预测 COVID-19 的严重程度和死亡率,而与医院喂养方式无关。

The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding method.

机构信息

Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA.

Program of Microbiome Dynamics, University of Massachusetts Chan Medical School , Worcester, Massachusetts, USA.

出版信息

mSystems. 2023 Aug 31;8(4):e0031023. doi: 10.1128/msystems.00310-23. Epub 2023 Aug 7.

DOI:10.1128/msystems.00310-23
PMID:37548476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10469851/
Abstract

SARS-CoV-2-positive patients exhibit gut and oral microbiome dysbiosis, which is associated with various aspects of COVID-19 disease (1-4). Here, we aim to identify gut and oral microbiome markers that predict COVID-19 severity in hospitalized patients, specifically severely ill patients compared to moderately ill ones. Moreover, we investigate whether hospital feeding (solid versus enteral), an important cofounder, influences the microbial composition of hospitalized COVID-19 patients. We used random forest classification machine learning models with interpretable secondary analyses. The gut, but not the oral microbiota, was a robust predictor of both COVID-19-related fatality and severity of hospitalized patients, with a higher predictive value than most clinical variables. In addition, perturbations of the gut microbiota due to enteral feeding did not associate with species that were predictive of COVID-19 severity. IMPORTANCE SARS-CoV-2 infection leads to wide-ranging, systemic symptoms with sometimes unpredictable morbidity and mortality. It is increasingly clear that the human microbiome plays an important role in how individuals respond to viral infections. Our study adds to important literature about the associations of gut microbiota and severe COVID-19 illness during the early phase of the pandemic before the availability of vaccines. Increased understanding of the interplay between microbiota and SARS-CoV-2 may lead to innovations in diagnostics, therapies, and clinical predictions.

摘要

SARS-CoV-2 阳性患者表现出肠道和口腔微生物组失调,这与 COVID-19 疾病的各个方面有关(1-4)。在这里,我们旨在确定肠道和口腔微生物组标志物,以预测住院患者 COVID-19 的严重程度,特别是与中度患者相比的重症患者。此外,我们还研究了医院喂养(固体与肠内)这一重要的混杂因素是否会影响住院 COVID-19 患者的微生物组成。我们使用了具有可解释性二次分析的随机森林分类机器学习模型。肠道微生物组,而不是口腔微生物组,是 COVID-19 相关死亡率和住院患者严重程度的可靠预测因子,其预测价值高于大多数临床变量。此外,由于肠内喂养而导致的肠道微生物组的扰动与预测 COVID-19 严重程度的物种无关。重要性 SARS-CoV-2 感染会导致广泛的全身性症状,有时会导致不可预测的发病率和死亡率。越来越清楚的是,人类微生物组在个体对病毒感染的反应中起着重要作用。我们的研究增加了在大流行早期(在疫苗可用之前)关于肠道微生物组与严重 COVID-19 疾病之间关联的重要文献。增加对微生物组和 SARS-CoV-2 之间相互作用的理解可能会导致诊断、治疗和临床预测的创新。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f5/10469851/74b070367efa/msystems.00310-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f5/10469851/264f34bacd17/msystems.00310-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f5/10469851/74b070367efa/msystems.00310-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f5/10469851/264f34bacd17/msystems.00310-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f5/10469851/74b070367efa/msystems.00310-23.f002.jpg

相似文献

1
The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding method.肠道微生物群可预测 COVID-19 的严重程度和死亡率,而与医院喂养方式无关。
mSystems. 2023 Aug 31;8(4):e0031023. doi: 10.1128/msystems.00310-23. Epub 2023 Aug 7.
2
Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.评估与 SARS-CoV-2 感染相关的肠道和上呼吸道中的微生物群。
Microbiome. 2023 Mar 3;11(1):38. doi: 10.1186/s40168-022-01447-0.
3
Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.肠道和气道微生物群及其在 COVID-19 感染和发病机制中的作用:范围综述。
Infection. 2022 Aug;50(4):815-847. doi: 10.1007/s15010-021-01715-5. Epub 2021 Oct 20.
4
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
5
The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.真菌肠道微生物组在严重 COVID-19 疾病中表现出多样性减少和子囊菌门相对丰度增加,并在 SARS-CoV-2 阳性患者中具有独特的相互关联的群落。
Front Cell Infect Microbiol. 2022 Apr 19;12:848650. doi: 10.3389/fcimb.2022.848650. eCollection 2022.
6
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
7
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.
8
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.危重症 2019 冠状病毒病(COVID-19)患者口咽微生物组中严重的生态失调及特定嗜血杆菌和奈瑟菌特征标志。
Clin Infect Dis. 2022 Aug 24;75(1):e1063-e1071. doi: 10.1093/cid/ciab902.
9
Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.在 SARS-CoV-2 大流行期间用于肠道微生物组生物矫正的当前药物靶点:系统评价。
Curr Drug Targets. 2022;23(11):1099-1125. doi: 10.2174/1389450123666220418094853.
10
Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.饮食调节的肠道微生物群对 SARS-CoV-2 感染的调控。
Front Cell Infect Microbiol. 2023 Jun 29;13:1167827. doi: 10.3389/fcimb.2023.1167827. eCollection 2023.

引用本文的文献

1
Bacteriome Signature in SARS-CoV-2-Infected Patients Correlates with Increased Gut Permeability and Systemic Inflammatory Cytokines.新冠病毒感染患者的细菌群落特征与肠道通透性增加和全身炎症细胞因子相关。
Microorganisms. 2025 Jun 16;13(6):1407. doi: 10.3390/microorganisms13061407.
2
The Role of Beneficial Microbiota in COVID-19: Insights from Key Bacterial Genera.有益微生物群在2019冠状病毒病中的作用:关键细菌属的见解
Microorganisms. 2025 Apr 29;13(5):1029. doi: 10.3390/microorganisms13051029.
3
Gut microbiome and clinical and lifestyle host factors associated with recurrent positive RT-PCR for SARS-CoV-2.

本文引用的文献

1
Ischemic Stroke Impacts the Gut Microbiome, Ileal Epithelial and Immune Homeostasis.缺血性中风影响肠道微生物群、回肠上皮和免疫稳态。
iScience. 2022 Oct 25;25(11):105437. doi: 10.1016/j.isci.2022.105437. eCollection 2022 Nov 18.
2
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia.抗生素治疗的 COVID-19 患者肠道微生物组失调与微生物易位和菌血症有关。
Nat Commun. 2022 Nov 1;13(1):5926. doi: 10.1038/s41467-022-33395-6.
3
Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
肠道微生物群以及与新冠病毒(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)反复呈阳性相关的临床和生活方式宿主因素。
Front Cell Infect Microbiol. 2024 Dec 18;14:1494193. doi: 10.3389/fcimb.2024.1494193. eCollection 2024.
4
Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data.基于 SARS-CoV-2 基因组多样性的 COVID-19 严重程度的可预测性和可解释性增强:一项涵盖四年数据的综合研究。
Sci Rep. 2024 Nov 6;14(1):26992. doi: 10.1038/s41598-024-78493-1.
5
Inhibition of SARS-CoV-2 infection by and the oral microbiome.抑制 SARS-CoV-2 感染的 和口腔微生物组。
Microbiol Spectr. 2024 Oct 3;12(10):e0059924. doi: 10.1128/spectrum.00599-24. Epub 2024 Aug 20.
COVID-19 患者肠道微生物组中短链脂肪酸和 L-异亮氨酸生物合成的长期损伤。
Gastroenterology. 2022 Feb;162(2):548-561.e4. doi: 10.1053/j.gastro.2021.10.013. Epub 2021 Oct 21.
4
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID.口腔微生物组炎症型失调与 COVID-19 症状持续时间和长新冠有关。
JCI Insight. 2021 Oct 22;6(20):e152346. doi: 10.1172/jci.insight.152346.
5
Gut microbiota, inflammation, and molecular signatures of host response to infection.肠道微生物群、炎症和宿主对感染的反应的分子特征。
J Genet Genomics. 2021 Sep 20;48(9):792-802. doi: 10.1016/j.jgg.2021.04.002. Epub 2021 May 3.
6
Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.肠道微生物群失调与中度新冠肺炎发热患者的异常免疫反应相关。
J Inflamm Res. 2021 Jun 17;14:2619-2631. doi: 10.2147/JIR.S311518. eCollection 2021.
7
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.肠道微生物群组成可预测人类结核病治疗期间外周炎症状态。
Nat Commun. 2021 Feb 18;12(1):1141. doi: 10.1038/s41467-021-21475-y.
8
Role of dietary fiber in the recovery of the human gut microbiome and its metabolome.膳食纤维在人类肠道微生物组及其代谢组恢复中的作用。
Cell Host Microbe. 2021 Mar 10;29(3):394-407.e5. doi: 10.1016/j.chom.2020.12.012. Epub 2021 Jan 12.
9
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.
10
Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer.基于人类肠道微生物群的知识库作为一种生物标志物筛选工具,以提高结直肠癌的预测概率。
Front Microbiol. 2020 Nov 19;11:596027. doi: 10.3389/fmicb.2020.596027. eCollection 2020.